COVID-19 treatment, Keytruda boost drugmaker Merck in Q1

Apr 28, 2022, 3:38 AM | Updated: 8:12 am
FILE - This undated photo provided by Merck & Co. shows their new antiviral medication molnupiravir...

FILE - This undated photo provided by Merck & Co. shows their new antiviral medication molnupiravir. COVID-19 patients have two new treatment options that can be taken at home. But that convenience comes with a catch: The pills have to be taken as soon as possible once symptoms appear. U.S. regulators authorized the pills from Pfizer and Merck late 2021. (Merck & Co. via AP, File)

(Merck & Co. via AP, File)

Merck soared past first-quarter expectations, helped by sales of its long-standing blockbuster cancer drug Keytruda and a new COVID-19 treatment that also topped forecasts.

The drugmaker raised its 2022 forecast Thursday after its coronavirus treatment molnupiravir brought in almost $3.2 billion in sales in the quarter.

Analysts were expecting $2.54 billion from the drug, which debuted late last year under the brand name Lagevrio.

Merck has said it expects the capsules to bring in sales of $5 billion or more this year. But analysts are starting to wonder whether all the treatment courses Merck makes will get used.

One analyst said on a Thursday call with company leaders that some data shows the treatment Paxlovid from rival Pfizer is being used much more frequently. The analyst noted that the U.S. has contracted to have 3.1 million courses of Lagevrio delivered and asked if there was a recourse for the government to return unused portions.

Chief Financial Officer Caroline Litchfield said the company expects the roughly 6.4 million treatment courses that it has delivered so far globally to be used over time, and the drugmaker remains “confident in our financials.”

She said data they have access to suggests that 500,000 people have used Lagevrio so far globally, and use has been particularly strong outside the United States.

Governments have been using and stockpiling both Lagevrio, which is also made by Ridgeback Biotherapeutics, and Paxlovid, which was shown to be more effective in clinical research, after the omicron surge of the virus filled hospitals earlier this year.

The treatments have been seen as a breakthrough in the fight to control the ongoing pandemic because they are effective and are easier for patients to use than other drugs that require injections or IV infusions.

The drugs are being used to treat patients most at risk of winding up in a hospital from the virus.

Both Lagevrio and Paxlovid must be used soon after COVID-19 symptoms appear, and U.S. President Joe Biden is pushing to expand their availability.

The treatments are free to patients in the U.S.

Not counting Lagevrio, Merck said its pharmaceutical revenue still grew 18% in the first quarter. Sales of Keytruda climbed 23% to $4.81 billion.

Overall, Merck’s profit climbed 36% to $4.31 billion.

Adjusted earnings, which exclude one-time items, totaled $2.14 per share. Total sales jumped 50% to $15.9 billion.

Analysts expected, on average, earnings of $1.83 per share on about $14.55 billion in revenue in the quarter.

The company also said Thursday it was raising and narrowing its forecast for the year. Merck now expects adjusted earnings to range between $7.24 and $7.36 per share after forecasting $7.12 to $7.27 per share in February.

Analysts expect earnings of $7.28 per share, according to FactSet.

Shares of Merck & Co. Inc., based in Kenilworth, New Jersey, climbed more than 3% to $87.38 late Thursday morning. The Dow Jones Industrial Average, of which Merck is a component, rose slightly.

___

Follow Tom Murphy on Twitter: https://twitter.com/thpmurphy

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

AP

FILE - Doja Cat performs at the Coachella Music & Arts Festival at the Empire Polo Club on Sunday, ...
Associated Press

BET Awards return Sunday with Doja Cat as leading nominee

LOS ANGELES (AP) — The BET Awards return Sunday with a live show that could see Doja Cat, Drake and Ari Lennox snag some trophies. Doja Cat enters the show as the leading nominee with six. The chart-topping performer is up for best female R&B-pop artist, best female hip-hop artist, album of the year for […]
22 hours ago
U.S. President Joe Biden, right, waves as he walks past Bavarian mountain riflemen and traditional ...
Associated Press

Biden, G-7 leaders huddle on energy, inflation, Ukraine war

ELMAU, Germany (AP) — President Joe Biden and his Group of Seven allies will huddle Sunday on strategies to secure energy supplies and tackle inflation, aiming to keep the fallout from Russia’s invasion of Ukraine from splintering the global coalition working to punish Moscow. Biden arrived in Germany’s picturesque Bavarian alps early Sunday morning for […]
22 hours ago
A staff member works at the Yuet Tung China Works, Hong Kong's porcelain factory, in Hong Kong, Wed...
Associated Press

AP PHOTOS: Hong Kong’s last hand-painted porcelain factory

HONG KONG (AP) — Step into Yuet Tung China Works, Hong Kong’s last remaining hand-painted porcelain factory, and you find yourself surrounded by stacks of dinnerware, each piece painstakingly decorated by hand with vibrant motifs of flowers, fruits and animals. Joseph Tso, the third-generation owner of the factory, and his small team are among the […]
22 hours ago
Associated Press

Today in History: June 26, first Harry Potter book published

Today in History Today is Sunday, June 26, the 177th day of 2022. There are 188 days left in the year. Today’s Highlight in History: On June 26, 1945, the charter of the United Nations was signed by 50 countries in San Francisco. On this date: In 1917, the first troops of the American Expeditionary […]
22 hours ago
Associated Press

Rep. Mary Miller calls Roe decision ‘victory for white life’

NEW YORK (AP) — U.S. Rep. Mary Miller of Illinois, speaking at a rally Saturday night with former President Donald Trump, called the Supreme Court’s decision overturning Roe v. Wade a “victory for white life.” Miller’s spokesman said the Illinois Republican had intended to say the decision was a victory for a “right to life.” […]
22 hours ago
FILE - This Sept. 20, 2017, file photo shows a sign at the Disney store on the Champs Elysees Avenu...
Associated Press

Abortion ruling thrusts companies into divisive arena

The Supreme Court’s decision to end the nation’s constitutional protections for abortion has catapulted businesses of all types into the most divisive corner of politics. Some companies that stayed silent last month — when a draft opinion by Justice Samuel Alito was leaked to Politico — spoke up for the first time Friday, including The […]
22 hours ago

Sponsored Articles

...
Carla Berg, MHS, Deputy Director, Public Health Services, Arizona Department of Health Services

Update your child’s vaccines before kindergarten

So, your little one starts kindergarten soon. How exciting! You still have a few months before the school year starts, so now’s the time to make sure students-to-be have the vaccines needed to stay safe as they head into a new chapter of life.
...
Day & Night Air

Tips to lower your energy bill in the Arizona heat

Does your summer electric bill make you groan? Are you looking for effective ways to reduce your bill?
...
Christina O’Haver

BE FAST to spot a stroke

Every 40 seconds—that’s how often someone has a stroke in the United States. It’s the fifth leading cause of death among Americans, with someone dying of a stroke every 3.5 minutes.
COVID-19 treatment, Keytruda boost drugmaker Merck in Q1